Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
02/1999
02/04/1999CA2296562A1 Aqueous liquid pharmaceutical composition containing as main component benzopyran derivative
02/04/1999CA2296518A1 Substituted 1,2,3,4-tetrahydronaphthalene derivatives
02/04/1999CA2296478A1 Antitumor agents
02/04/1999CA2296426A1 Novel compounds
02/04/1999CA2296329A1 Aminocycloalkane compounds
02/04/1999CA2296314A1 Cyclic amine modulators of chemokine receptor activity
02/04/1999CA2295037A1 Aqueous compositions comprising ranitidine and lcmt sucrose
02/04/1999CA2294300A1 Urokinase inhibitors
02/04/1999CA2291781A1 Carcinostatics
02/04/1999CA2266891A1 Amidino-camptothecin derivatives
02/04/1999CA2239267A1 Novel compounds
02/03/1999EP0894863A1 A YAK-1 related serine/threonine protein kinase-HTLAR33
02/03/1999EP0894862A2 Novel CysS
02/03/1999EP0894861A2 Glycogen phosphorylase from Streptococcus pneumoniae
02/03/1999EP0894858A2 Prolyl tRNA synthetase from Streptococcus pneumoniae
02/03/1999EP0894856A1 A human sMAD3 splice variant
02/03/1999EP0894854A2 A novel splicing variant of the epstein-barr virus-induced g-protein coupled receptor
02/03/1999EP0894853A1 Transcriptional silencer protein NRF, nucleic acid molecules encoding it and their use
02/03/1999EP0894806A1 Novel pheS
02/03/1999EP0894805A1 Ribose substituted aromatic derivatives, their preparation and use as medicaments
02/03/1999EP0894796A1 Imidazolines substituted with a heterocyclic ring as alpha-2 antagonists
02/03/1999EP0894795A1 Benzimidazole, benzoxazole and benzothiazole derivatives, their preparation and pharmaceutical compositions containing them
02/03/1999EP0894789A1 Substituted indole-2-carboxylic acids as glucosyl transferase inhibitors
02/03/1999EP0894497A1 Use of substituted imidazolidin-2,4-diones as analgesics
02/03/1999EP0894496A1 Neovascularization inhibitor
02/03/1999EP0894494A2 Cell renewal rate compositions
02/03/1999EP0894144A2 Diagnosing trinucleotide repeat diseases and genes involved therein
02/03/1999EP0894140A1 Allele suppression
02/03/1999EP0894139A1 Sensitization of her-2/neu overexpressing cancer cells to chemotherapy
02/03/1999EP0894137A1 Novel human myeloid terminal differentiation response gene
02/03/1999EP0894136A1 Method of treating muscular disorders
02/03/1999EP0894135A1 Multivalent and multispecific antigen-binding protein
02/03/1999EP0894133A2 Neuropeptide y receptor y5 and nucleic acid sequence
02/03/1999EP0894130A1 Modulators of tnf receptor associated factor (traf), their preparation and use
02/03/1999EP0894129A1 Short external guide sequences
02/03/1999EP0894092A1 A cyclic hepta-peptide derivative from colonial ascidians, lissoclinum sp.
02/03/1999EP0894089A1 Novel heterocyclic compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them
02/03/1999EP0894088A1 Substituted sulfonic acid n- (aminoiminomethyl)phenylalkyl]-azaheterocyclamide compounds
02/03/1999EP0894085A1 Benzyl(idene)-lactam derivatives, their preparation and their use as selective (ant)agonists of 5-ht1a- and/or 5-ht1d receptors
02/03/1999EP0894084A1 Cinnamic acid derivatives and their use as integrin antagonists
02/03/1999EP0894083A1 Creatine pyruvates and method for their production
02/03/1999EP0894011A2 Delivery of nucleic acids by porphyrins
02/03/1999EP0894010A2 Denaturants for sympathomimetic amine salts
02/03/1999EP0894009A1 Improved vision through photodynamic therapy of the eye
02/03/1999EP0894008A1 Method of producing immunogenic products and vaccines
02/03/1999EP0894006A1 POLYNUCLEOTIDES AND POLYPEPTIDES OF THE THREONYL tRNA SYNTHETASE FAMILY
02/03/1999EP0894004A1 Methods for enhancing functional recovery following central nervous system ischemia or trauma
02/03/1999EP0894003A1 N-formyl hydroxylamine containing compounds useful as ace inhibitors and/or nep inhibitors
02/03/1999EP0894002A1 Novel peptides which inhibit complement activation
02/03/1999EP0894001A1 Inhibitor of immunoglobulin e antibody production
02/03/1999EP0894000A1 Method for delivering estrogen
02/03/1999EP0893999A1 Process for producing efonidipine hydrochloride preparations
02/03/1999EP0893998A1 Colonic delivery of nicotine to treat inflammatory bowel disease
02/03/1999EP0893997A1 Paroxetine in treatment of depression
02/03/1999EP0893996A1 Use of rapamycin derivatives in vasculopathies and xenotransplantation
02/03/1999EP0893995A1 Anticachectic composition
02/03/1999EP0893994A2 Diclofenac/gamma-cyclodextrin inclusion compounds
02/03/1999EP0893993A1 Method for attenuation of sympathetic nervous system activity or onset of migraine by selectively metabolized beta-blocking agents
02/03/1999EP0893992A2 Fast disintegrating oral dosage form
02/03/1999EP0893990A1 Ophthalmological composition of the type which undergoes liquid-gel phase transition
02/03/1999EP0893987A1 Sunscreen composition comprising a solid elastomeric organopolysiloxane
02/03/1999EP0893951A1 METHODS OF MODULATING RADICAL FORMATION BY MUTANT CuZnSOD ENZYMES
02/03/1999EP0862553A4 Cbi analogs of cc-1065 and the duocarmycins
02/03/1999EP0793649B1 18,19-dinor-vitamin d compounds
02/03/1999EP0786996A4 Cysteine protease and serine protease inhibitors
02/03/1999EP0777414B1 Sprayable film forming system releasing active substances for use on plants
02/03/1999EP0773938B1 Semi-synthetic taxanes with anti-tumoural activity
02/03/1999EP0763038B1 The preparation of nalbuphine having low levels of beta-epimer
02/03/1999EP0753000B1 Trinuclear cationic platinum complexes having antitumour activity and pharmaceutical compositions containing them
02/03/1999EP0729352B1 Interdigitation-fusion liposomes containing arachidonic acid metabolites
02/03/1999EP0699202B1 Calanolide and related antiviral compounds, compositions, and uses thereof
02/03/1999EP0669918B1 Furyl or thienyl carbonyl substituted taxanes and pharmaceutical compositions containing them
02/03/1999EP0652747B1 Controlled release morphine preparation
02/03/1999EP0649274B1 Aqueous compositions comprising an organic peroxiacid
02/03/1999EP0632794B1 Method for separating enantiomers of aryloxipropanolamine derivatives, and chiral solid-phase chromatography material for use in the method
02/03/1999EP0576425B1 Method for inactivating sperm
02/03/1999EP0510186B1 Therapeutic uses of melanin
02/03/1999CN1207131A Recombinant fusion proteins to growth hormone and serum albumin
02/03/1999CN1207102A 5h,10h-imidazo[1,2-alpha] indeno [1,2-3] pyrazine-4-one derivatives preparation thereof, intermediates thereof and drugs containing same
02/03/1999CN1207101A Novel tricyclic compounds for the inhibition of the ice/ced-3 protease family of enzymes
02/03/1999CN1207100A Novel indole-2,3-done-3-oxime derivatives
02/03/1999CN1207098A Amidine and isothiourea derivatives as inhibitors of nitric oxide synthase
02/03/1999CN1207097A Novel substituted 4-(1H-benzimidazol-2-YL) [1,4] diazepanes useful for the treatment of allergic diseases
02/03/1999CN1207096A 3-azetidinylalkylpiperidines or-pyrrolidines as tachykinin antagonists
02/03/1999CN1207095A Protease inhibitors
02/03/1999CN1207094A Phenyl thiazole derivatives with anti herpes virus properties
02/03/1999CN1207091A 1-arylsulphonyl, aryl(thio) carbonyl pyridazino derivatives and methods of preparation
02/03/1999CN1207049A Skin-adhering pharmaceutical preparation, in particular transdermal therapeutic system for the release of 17-'beta'-estradiol to the human organism
02/03/1999CN1207045A Nisin in combination with glycerol monolaurate active against helicobacter
02/03/1999CN1207042A A Pharmaceutical composition for the treatment of autommune diseases
02/03/1999CN1207041A Antineoplastic method and compositions employing optically pure (-)-fotemustine
02/03/1999CN1207040A Antineoplastic methods and compositions employing (+)-fotemustine
02/03/1999CN1207039A Treatment of traumatic brain injury
02/03/1999CN1207038A Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of menopausal symptoms
02/03/1999CN1207037A Use of the L-enantiomer of centchroman for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of breast cancer
02/03/1999CN1206714A Oligomeric deoxynucleotide of vascular endothelial cell growth factor
02/03/1999CN1206712A Heterocyclic compound, preparation process thereof and medicinal composition containing same
02/03/1999CN1206590A Shuangzuoxing suppository and ointment
02/03/1999CN1206589A Process for preparing medicine composition
02/03/1999CN1206588A Application of diversine in preparing medicine for curing uveitis eye diseases
1 ... 6544 6545 6546 6547 6548 6549 6550 6551 6552 6553 6554 6555 6556 6557 6558 6559 6560 6561 6562 6563 6564 ... 7860